These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1990435)

  • 1. Biotech nightmare: does Cetus own PCR?
    Barinaga M
    Science; 1991 Feb; 251(4995):739-40. PubMed ID: 1990435
    [No Abstract]   [Full Text] [Related]  

  • 2. US Supreme Court decision could compromise biotech patents.
    Robertson D
    Nat Biotechnol; 2001 May; 19(5):394. PubMed ID: 11328981
    [No Abstract]   [Full Text] [Related]  

  • 3. Napster case spills into biotech sector.
    Bouchie A
    Nat Biotechnol; 2004 Sep; 22(9):1185-6. PubMed ID: 15384189
    [No Abstract]   [Full Text] [Related]  

  • 4. The CREATE Act: increasing costs associated with the biotech industry?
    Mills AE; Chen DT; Gillon JJ; Tereskerz PM
    Nat Biotechnol; 2006 Jul; 24(7):785-6. PubMed ID: 16841059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 6. New rulings on the Cetus patent for taq polymerase.
    Leonard DG; Schifreen RS; Sninsky JJ; White TJ
    Mol Diagn; 2000 Mar; 5(1):1-3. PubMed ID: 10837081
    [No Abstract]   [Full Text] [Related]  

  • 7. Cetus retains PCR patents.
    Schaefer E
    Nature; 1991 Mar; 350(6313):6. PubMed ID: 2002846
    [No Abstract]   [Full Text] [Related]  

  • 8. Navigating the future(s) of biotech intellectual property.
    Cukier KN
    Nat Biotechnol; 2006 Mar; 24(3):249-51. PubMed ID: 16525371
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotechnology patents: strategies for meeting economic and ethical concerns.
    Gold ER
    Nat Genet; 2002 Apr; 30(4):359. PubMed ID: 11925560
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech patents and the inequitable conduct doctrine.
    Michael A
    Nat Biotechnol; 2006 Oct; 24(10):1219-21. PubMed ID: 17033655
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotech in post-TRIPS India.
    Ramani SV; Pradhan P; Ravi M
    Nat Biotechnol; 2005 Jan; 23(1):18-9. PubMed ID: 15637608
    [No Abstract]   [Full Text] [Related]  

  • 12. And the winner: Cetus does own PCR.
    Barinaga M
    Science; 1991 Mar; 251(4998):1174. PubMed ID: 2006407
    [No Abstract]   [Full Text] [Related]  

  • 13. A researcher's guide to patents.
    Shear RH; Kelley TE
    Plant Physiol; 2003 Jul; 132(3):1127-30. PubMed ID: 12857793
    [No Abstract]   [Full Text] [Related]  

  • 14. Equivalents in biotechnology patents.
    Auer HE
    Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotech patents: looking backward while moving forward.
    Eisenberg RS
    Nat Biotechnol; 2006 Mar; 24(3):317-9. PubMed ID: 16525404
    [No Abstract]   [Full Text] [Related]  

  • 16. Patenting biotech beyond the central dogma.
    Wu G
    Nat Biotechnol; 2010 Mar; 28(3):230-3. PubMed ID: 20212482
    [No Abstract]   [Full Text] [Related]  

  • 17. Super-enzyme patents get their day in court.
    Cyranoski D
    Nature; 2002 Oct; 419(6909):767. PubMed ID: 12397315
    [No Abstract]   [Full Text] [Related]  

  • 18. US court bolsters biotech patent protection.
    Harrison C
    Nat Biotechnol; 2011 Aug; 29(8):672-3. PubMed ID: 21822224
    [No Abstract]   [Full Text] [Related]  

  • 19. European Commission rethinks biotech patents.
    Mitchell P
    Nat Biotechnol; 2002 Dec; 20(12):1175-6. PubMed ID: 12454654
    [No Abstract]   [Full Text] [Related]  

  • 20. US Supreme Court applies strict limits to patents.
    Robertson D
    Nat Biotechnol; 2002 Jul; 20(7):639. PubMed ID: 12089532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.